HRA Pharma Reveals Big Growth Ambition: Become Top 10 OTC Player
You may also be interested in...
HRA promotes morning-after manners
Empowering both men and women to make responsible choices when it comes to contraception is the aim of a new educational campaign from HRA Pharma in support of its EllaOne (ulipristal acetate) emergency contraceptive in the UK.
HRA Pharma eagerly seeking acquisitions
HRA Pharma is aggressively seeking out acquisitions to help it become one of the fastest-growing OTC companies in the world, according to the firm’s president and chief executive officer David Wright.
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.